Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Forest Laboratories
With
AstraZeneca
To evaluate safety, effectiveness, pharmacokinetics and tolerance of ceftaroline fosamil in children who are initially hospitalized with Community Acquired Bacterial Pneumonia (CABP)
Age
0–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, 2 months to \< 18 years old.
Presence of CABP requiring hospitalization and IV antibacterial therapy
You may not be if
Documented history of any hypersensitivity of allergic reaction to any β-lactam antimicrobial.
Confirmed or suspected infection with a pathogen known to be resistant to ceftriaxone.
Confirmed or suspected respiratory tract infection attributed to sources other than CABP pathogens.
Non-infectious causes of pulmonary infiltrates.
Clareo Health | Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)
